Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. Lee, P., Bubeck, S., & Petro, J. New England Journal of Medicine, 388(13):1233–1239, March, 2023. Publisher: Massachusetts Medical Society _eprint: https://www.nejm.org/doi/pdf/10.1056/NEJMsr2214184
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine [link]Paper  doi  bibtex   
@article{lee_benefits_2023,
	title = {Benefits, {Limits}, and {Risks} of {GPT}-4 as an {AI} {Chatbot} for {Medicine}},
	volume = {388},
	issn = {0028-4793},
	url = {https://www.nejm.org/doi/full/10.1056/NEJMsr2214184},
	doi = {10.1056/NEJMsr2214184},
	number = {13},
	urldate = {2023-03-29},
	journal = {New England Journal of Medicine},
	author = {Lee, Peter and Bubeck, Sebastien and Petro, Joseph},
	month = mar,
	year = {2023},
	pmid = {36988602},
	note = {Publisher: Massachusetts Medical Society
\_eprint: https://www.nejm.org/doi/pdf/10.1056/NEJMsr2214184},
	keywords = {notion},
	pages = {1233--1239},
}

Downloads: 0